Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

126.55 -1.50 (-1.17%)
Official Closing Price Updated: 4:10 PM EDT, Sep 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 984,960
Open 127.29
Bid (Size) 126.10 (2)
Ask (Size) 131.00 (1)
Prev. Close 128.05
Today's Range 126.09 - 127.29
52wk Range 96.06 - 130.46
Shares Outstanding N/A
Dividend Yield 3.16%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wall Street Cheers Nebius-Microsoft Megadeal While Apple Misses the Mark
U.S. markets closed higher on Tuesday, buoyed by fresh labor data signaling a cooling job market—potentially paving the way for Fed rate cuts. Nebius soared nearly 50% on a multibillion-dollar AI-cloud... 
Via Chartmill
Topics Economy
Trump's Biotech Playbook Ignites $350 Billion Investment Blitz
Trump's policies have sparked a $350B investment surge in US biotech, creating job & revenue opportunities. Investors can track with XBI or IBB ETFs and consider JNJ, NVS, LLY, AZN, BMY as potential... 
Via Benzinga
Topics ETFs Government

Performance

YTD
+30.3%
+30.3%
1 Month
+6.7%
+6.7%
3 Month
+6.7%
+6.7%
6 Month
+13.7%
+13.7%
1 Year
+8.0%
+8.0%

More News

Read More
Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense'
Via Investor's Business Daily
Novartis Snaps Up Cardio-Focused Tourmaline Bio For $1.4 Billion
Via Investor's Business Daily
Tourmaline Bio Stock Just Rocketed 58% Pre-Market – Here’s What Happened
Via Stocktwits
Arrowhead Stock Rockets 11% Today – Retail Says $200M Upfront Payment From Novartis Collaboration Is ‘Hell Of A Deal’
Via Stocktwits
Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver
Via MarketBeat
Novartis To Expand Heart Drug Portfolio With $1.4 Billion Tourmaline Bio Acquisition
Via Benzinga
2024 R&D Spending and Intensity Benchmarks
Via PRLog
Topics Supply Chain
Novartis AG (NYSE:NVS) Offers a Compelling Mix of Dividend Yield, Profitability, and Financial Health
Via Chartmill
1 High-Yield Vanguard Dividend Fund to Buy Hand Over Fist
Via The Motley Fool
Topics ETFs Stocks
Why Shares in Arrowhead Pharmaceuticals Surged on News of a Novartis Deal
Via The Motley Fool
Palantir Deepens Industry Ties As Lear And Lumen Embrace Its AI Platforms
Via Benzinga
Topics Artificial Intelligence
Palantir Hosts Eighth AIPCon. Stays Above 50-Day Line. Is PLTR Stock A Buy?
Via Investor's Business Daily
Topics Artificial Intelligence ETFs Government
Why Did Bollinger Innovations Stock Plunge 18% Today?
Via Stocktwits
Arrowhead Pharma Jumps After Inking A Deal Worth Up To $2.2 Billion
Via Investor's Business Daily
Gateway to Growth: Innovation and Opportunity at the 8th CIIE
Via Press Release Distribution Service
Topics Economy
Gateway to Growth: Innovation and Opportunity at the 8th CIIE
Via Get News
Topics Economy
Novo Nordisk Slowdown Weighs On Denmark's Economic Outlook
Via Benzinga
Global Trade Braces for Impact: US-China Tariff Tensions Persist Amidst Fleeting Truces and Escalating Duties
Via MarketMinute
Topics Artificial Intelligence Economy Government
FDA Eases Monitoring Burden For Kidney Disease Patients On Travere Therapeutics' Filspari
Via Benzinga
Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
UK Drug Pricing Talks Collapse, Drugmakers Reject Offer Citing 'Uncompetitive' System
Via Benzinga
Novartis AG-Sponsored ADR (NYSE:NVS) – A Top Dividend Stock with Strong Yield and Financial Stability
Via Chartmill
Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 126.55
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 09/10/25 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.